Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
6.71M
-
Shares change
-
+5.5K
-
Total reported value, excl. options
-
$33.7M
-
Value change
-
-$278K
-
Put/Call ratio
-
0.44
-
Number of buys
-
36
-
Number of sells
-
-18
-
Price
-
$5.02
Significant Holders of NOVAVAX, INC. - Common Stock, Par Value $0.01 per share (NVAX) as of Q3 2019
92 filings reported holding NVAX - NOVAVAX, INC. - Common Stock, Par Value $0.01 per share as of Q3 2019.
NOVAVAX, INC. - Common Stock, Par Value $0.01 per share (NVAX) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.71M shares
of 162M outstanding shares and own 4.15% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.88M shares), VANGUARD GROUP INC (1.55M shares), MORGAN STANLEY (494K shares), STATE STREET CORP (424K shares), GEODE CAPITAL MANAGEMENT, LLC (362K shares), NORTHERN TRUST CORP (286K shares), Rock Springs Capital Management LP (163K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (139K shares), Bank of New York Mellon Corp (133K shares), and Nuveen Asset Management, LLC (96.7K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.